Safety and Feasibility of Sulforaphane to Promote Early Haematopoietic Recovery After Cord Blood Transplantation

Clinical trial NCT07297576 · RECRUITING

Trial details

NCT number: NCT07297576
Sponsor: Institute of Hematology & Blood Diseases Hospital, China
Status: RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

ALL (Acute B-Lymphoblastic Leukemia)AML (Acute Myelogenous Leukemia MDS (Myelodysplastic Syndrome)

Start date: 2025-10-22
Primary completion: 2027-06-01
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.